
Datamonk
Clean AI-ready imaging data
Amsterdam, Netherlands
Datamonk is the data quality layer for healthcare, starting with medical imaging. They build a unified AI engine that analyzes, cleanses, and normalizes imaging data at scale by reading both metadata and pixels. By turning dirty archives into trustworthy, AI-ready data, they power better clinical workflows, seamless PACS/VNA migrations, and robust research datasets.

How We Help
Leadership
Problem Statement
Dirty medical imaging data slows down clinical workflows, hinders medical research, and degrades the performance of healthcare AI models.
Core Technology
own models, workflow on top of AWS
Key Differentiators
Their AI engine uniquely validates metadata directly against pixel data. The platform is built by founders with two exits and 45 years in healthcare data, trusted by PACS vendors and US data platforms.
Target Customers
Hospitals, PACS vendors, and US data platforms
Company Info
- Business Model
- License + Usage
- Founded
- 2024
- Total Funding
- Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now - Website
- datamonk.ai
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
As a data infrastructure layer, Datamonk operates outside medical device regulation. The platform's performance has been validated across 5+ successful real-world enterprise engagements, demonstrating its ability to accurately cleanse and normalize complex imaging datasets at scale.
Only accessible to MedStartr community members.
Join nowWhat do you think of Datamonk?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Comments
Comments from new members are shown once the company's team has approved them. Please follow the community rules.
Sign in to join the conversation.
Sign in to comment